Oriola (HLSE:ORIOLA) Stock Faces Ongoing Loss As Q2 EPS Stays Negative

Oriola Oyj (HLSE:ORIOLA) opened Q2 2026 with revenue of €51.8 million and a reported EPS loss of €0.007, alongside net income that remained in the red at a €1.3 million loss. Over recent quarters the company has seen revenue move from €50.9 million in Q2 2025 to €49.8 million in Q1 2026 and then to €51.8 million in Q2 2026, while EPS has ranged from a loss of €0.030 in Q2 2025 to a narrower loss of €0.011 in Q1 2026 and €0.007 in the latest quarter. This sets up an earnings release in which investors will be focused on whether margins are starting to stabilise.

See our full analysis for Oriola Oyj.

With the quarterly numbers on the table, the next step is to weigh these results against the prevailing narratives around Oriola's growth potential, risk profile, and path back to stronger margins.

See what the community is saying about Oriola Oyj

Losses Narrow, But Oriola Still In The Red

• Oriola Oyj reported a loss of €1.3 million in Q2 2026, which is smaller than the €2 million loss in Q1 2026 and the €5.6 million loss in Q2 2025, while trailing twelve month net income is a €19.5 million loss on €1.9b of revenue.
• Bulls focus on the idea that earnings are forecast to grow 31.34% per year and eventually turn positive. However, the trailing twelve month loss of €19.5 million and a five year trend where losses deepened at about 60.8% annually create a clear tension between the hoped for earnings recovery and the reality that Oriola has not yet produced consistent profits.
  • Supporters point to revenue growth presented at around 4.7% per year as the base for an earnings rebound, but the ongoing losses show that higher sales alone have not yet translated into sustained positive net income.
  • The expectation that Oriola could become profitable within three years sits against the fact that even the latest quarter still shows a loss and the last twelve months together have not moved the company out of negative earnings.

Bulls looking closer at this shift in losses might want to see how the optimistic case is built across different scenarios in more depth 🐂 Oriola Oyj Bull Case

Dividend And Dilution Put Pressure On Shareholders

• The stock currently carries a dividend yield of 7.56%, yet that payout is flagged as not covered by current earnings or free cash flow, and comes after substantial shareholder dilution over the past year.
• Bears highlight that an uncovered dividend combined with recent dilution makes the capital return story fragile, and the trailing twelve month loss of €19.5 million along with five years of worsening losses give those concerns specific footing.
  • The company has been unprofitable over the last year, so dividend cash is not coming from surplus earnings, which reinforces the worry that the current payout level may be putting extra strain on the balance sheet.
  • Shareholders have already seen their ownership percentage reduced by dilution, so if weak earnings persist while the dividend stays high, skeptics see a risk that future funding needs could further weigh on existing investors.

If you are trying to understand how cautious investors connect these dividend and dilution flags to the wider Oriola story, it helps to see the detailed bear case laid out side by side with the numbers 🐻 Oriola Oyj Bear Case

Low P/S Multiple And DCF Gap Stand Out

• Oriola trades on a P/S of 0.1x compared with about 0.8x for the wider European Healthcare industry and 5.2x for peers, while the current share price of €0.926 sits well below a DCF fair value of €3.12 and also below an analyst price target of €0.99.
• Supporters arguing that Oriola looks inexpensive point to this large gap to DCF fair value and lower P/S ratio as potential upside signals. Critics, however, can point back to the €19.5 million trailing twelve month loss and long run loss trend to argue that the discount reflects real business risk rather than a simple mispricing.
  • The combination of a P/S multiple far below both industry and peer averages with a modeled fair value over 3x the current price is the core of the potential value argument.
  • At the same time, the long history of losses, recent dilution, and uncovered 7.56% dividend show that any appeal in the low multiple comes with meaningful fundamental issues that investors need to factor in.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Oriola Oyj on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Seeing mixed signals around Oriola Oyj and not sure what to make of them? Take a closer look at both sides of the story with 3 key rewards and 2 important warning signs

See What Else Is Out There

Oriola Oyj is still reporting losses, an uncovered 7.56% dividend, and shareholder dilution, which together raise questions about the resilience of its earnings and capital returns.

If that mix of ongoing losses and balance sheet strain feels uncomfortable, it is worth checking stocks with stronger cushions using the solid balance sheet and fundamentals stocks screener (416 results) so you can compare Oriola against companies with sturdier financial foundations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com